Life Science Stocks At Ease After 5% Gain in November Stocks Come Back In Late Day Trading 12/4 After 3 down days with the S&P, biotechnology stocks are holding near sector highs with the IBB at $221. Other widely traded ETFS (PBE,XBI) have also held near their highs of last week. There is now a nice […]
Large Cap Biotechs Rocketing Up:BIIB, GILD Despite a flattish Dow and S&P, many life science stocks are surging ahead. There are many movers in the Rayno Biopharmaceutical Portfolio : Biogen Idec BIIB $277) up 10%, Gilead (GILD $74.40) up 3.88% and Regeneron (REGN $283) up 2.38%. Clinical trial and regulatory news is the trigger. Biogen Idec […]
Strong Jobs Report Boosts Market–Treasuries Sell -Off with 10 Year up to 2.74% Volatile Week Finds Buyers-Technical Levels Hold 11/8/13 9:45 a Biotechnology stocks rebounded today with the IBB up 3% to $203.86. The sector hit a major downdraft yesterday but we are still well above Q3 lows (IBB) on October 9. The rebound is […]
Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%. Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off harder than larger caps with revenues and […]
Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund (FBIOX $171) is up 54.5% YTD. You can see our top picks […]
Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at new highs with the major indices at or near their October highs. The bellwether ETF IBB ($211.30) is flat after the index was […]
